A downtrend has been apparent in Mesoblast Limited (MESO) lately. While the stock has lost 10.8% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last ...

We recently published 7 Best ASX Stocks to Buy Right Now. Mesoblast Limited (NASDAQ:MESO) is one of the best ASX stocks. Mesoblast Limited (NASDAQ:MESO) is a biotechnology company developing ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." ...

The average one-year price target for Mesoblast Limited - Depositary Receipt (NasdaqGS:MESO) has been revised to $20.25 / share. This is an increase of 11.48% from the prior estimate of $18.16 dated ...

Mesoblast's remestemcel (Ryoncil) is FDA-approved for steroid-refractory acute graft-versus-host disease in patients two months and older, marking a significant milestone for MSC therapies in the US.

Mesoblast Limited is advancing innovative cellular therapies, with Remestemcel-L for pediatric SR-aGVHD nearing FDA approval and a PDUFA date set for January 2025. Positive Phase 3 results indicate ...

A team of fintech-turned-crypto converts today launched Meso, a payment platform that brings digital assets and fiat currencies closer together, making it easier for users to move money on- and ...

MESO is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of MESO shares has decreased $0.54 since the market last closed. This is a 2.91% ...

San Jose’s new Meso Modern Mediterranean has just opened, and it’s made us realize that complete as Santana Row’s dining scene may have felt before, there was definitely room for one more hot spot.